Bactiguard delivered its fourth straight quarter of positive EBITDA, with Q1 2025 revenues up 7% year-over-year and strong growth in Wound Management. Strategic partnerships and updated long-term targets support continued profitable expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.